Search

Author/Creator Feltquate, David

1. Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in Oncology. (17th December 2018)

Authors:
Hobbs, Brian P; Barata, Pedro C; Kanjanapan, Yada; Paller, Channing J; Perlmutter, Jane; Pond, Gregory R; Prowell, Tatiana M; Rubin, Eric H; Seymour, Lesley K; Wages, Nolan A; Yap, Timothy A; Feltquate, David; Garrett-Mayer, Elizabeth; Grossman, William; Hong, David S; Ivy, S Percy; Siu, Lillian ...
Journal:
Journal of the National Cancer Institute
Issue:
Volume 111:Number 2(2019)
Page Start:
118
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with targeted therapies. Issue 3 (14th March 2023)

Authors:
Atkins, Michael B; Ascierto, Paolo A; Feltquate, David; Gulley, James L; Johnson, Douglas B; Khushalani, Nikhil I; Sosman, Jeffrey; Yap, Timonthy A; Kluger, Harriet; Sullivan, Ryan J; Tawbi, Hussein
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 11:Issue 3(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology. Issue 3 (31st March 2023)

Authors:
Naidoo, Jarushka; Murphy, Catherine; Atkins, Michael B; Brahmer, Julie R; Champiat, Stephane; Feltquate, David; Krug, Lee M; Moslehi, Javid; Pietanza, M Catherine; Riemer, Joanne; Robert, Caroline; Sharon, Elad; Suarez-Almazor, Maria E; Suresh, Karthik; Turner, Michelle; Weber, Jeffrey; Cappelli,...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 11:Issue 3(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗